iBio, Inc. (IBIO) stock
IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.80−0.05 (-5.55%)
Close on Nov 19, 2026Market cap $51.51MP/E –Yield –
iBio shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
iBio's shares outstanding was 152M at Sep 30, 2026. For fiscal 2026 it was 104M, up 891.1% from the year before. Over ten years it grew 140.3% a year on average. The highest annual figure on record is 104M in fiscal 2026.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | 104M | +891.1% |
| FY2025 | Jun 30, 2025 | 10M | +174.1% |
| FY2024 | Jun 30, 2024 | 4M | +526.0% |
| FY2023 | Jun 30, 2023 | 1M | +40.4% |
| FY2022 | Jun 30, 2022 | 0M | +11.5% |
| FY2021 | Jun 30, 2021 | 0M | +211.5% |
| FY2020 | Jun 30, 2020 | 0M | +231.8% |
| FY2019 | Jun 30, 2019 | 0M | +78.0% |
| FY2018 | Jun 30, 2018 | 0M | +19.3% |
| FY2017 | Jun 30, 2017 | 0M | +10.0% |
| FY2016 | Jun 30, 2016 | 0M | +13.3% |
| FY2015 | Jun 30, 2015 | 0M | +13.5% |
| FY2014 | Jun 30, 2014 | 0M | +27.5% |
| FY2013 | Jun 30, 2013 | 0M | +123350.0% |
| FY2012 | Jun 30, 2012 | 0M | -99.9% |
| FY2011 | Jun 30, 2011 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | 152M | +186.1% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | 145M | +910.1% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | 120M | +1112.7% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | 99M | +985.6% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | 53M | +513.7% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | 14M | +287.6% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | 10M | +431.4% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | 9M | +662.3% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | 9M | +906.2% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | 4M | +463.4% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | 2M | +278.8% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | 1M | +171.0% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | 1M | +96.6% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | 1M | +51.2% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | 0M | +12.9% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | 0M | +2.6% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | 0M | +16.0% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | 0M | +34.2% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | 0M | +97.1% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | 0M | +269323.8% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | 0M | +508243.2% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | 0M | +738272.7% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | 0M | +453.0% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | 0M | +321.1% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | 0M | +100.0% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | 0M | +22.2% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | 0M | +69.0% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | 0M | -99.8% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | 0M | -99.8% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | 0M | -99.8% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | 0M | +32.2% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | 0M | +29.6% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | 0M | +8.4% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | 0M | +3.1% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | 0M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | 0M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | 0M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | 0M | – |
See a number that looks wrong?